Stonesifer stated, "We expect top line growth of between 5% and 7%." He added, "We expect core diluted EPS to grow between 9% and 12%" for 2026. The outlook assumes aggregate eye care markets grow 3% ...
CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent innovation launches, citing ...